NRX Pharmaceuticals, Inc. NRXP
- KETAFREE — Suicidal Ideation in Depression NDA Submitted
- D-cycloserine — Bipolar Depression NDA Submitted
- D-cycloserine — Major Depressive Disorder Phase 3
Home › Targets › NMDA receptor
NMDA receptor (1 companies · 3 programs)
Companies with an active program directed at NMDA receptor.